Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Research
    • Structural Heart Disease
    • TAVR
    • Therapies
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home
News You Need to Know Today
News Alert: FDA announces recall of 2 cardiovascular medications due to labeling mix-up
Friday, September 30, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA announces recall of 2 cardiovascular medications due to labeling mix-up

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 

READ MORE >
FDA recall. The medications involved are atenolol, which treats hypertension, and the antiplatelet agent clopidogrel, which reduces the risk of an acute myocardial infarction (AMI) or stroke among patients with a history of AMI, severe chest pain or circulation problems.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of 2 cardiovascular medications due to labeling mix-up

Share on Twitter Share on Facebook Share on Linkedin
FDA recall. The medications involved are atenolol, which treats hypertension, and the antiplatelet agent clopidogrel, which reduces the risk of an acute myocardial infarction (AMI) or stroke among patients with a history of AMI, severe chest pain or circulation problems.
Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Emergency cardiovascular care & COVID-19 | Statins reduce risk of developing HF from breast cancer therapies
Healthcare Economics & Policy | March 2020
4 coronavirus considerations | Hypertension-related death skyrockets | Covid-19 unkind to heart patients
What COVID-19 means for cath labs | Mental stress associated with repeat heart attacks | Cannabis & cardiology
Week in Review: Key COVID-19 updates | Stem cell therapy and heart attacks | Risk of death from stroke drops 24%
AHA's role during COVID-19 pandemic | Risk of death from stroke drops 24% | A new warning for heart patients
Electrophysiology & Arrhythmia | March 2020

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …241
    • Page 242
    • Page 243
    • Page 244
    • Page 245
    • Page 246
    • Current page 247
    • Page 248
    • Page 249
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Sitemap
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • AI in Healthcare
  • Cardiovascular Business
  • HealthExec
  • Health Imaging
  • Radiology Business
 
© 2024 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme